Aumolertinib as Neoadjuvant and Adjuvant Therapy for Unresectable Stage IIIA-IVA Non-Small Cell Lung Cancer with EGFR Mutations

被引：0
|
作者：
Shao, F. [1 ]
Zhang, Q. [1 ]
Cheng, W. [1 ]
Liu, N. [1 ]
Fang, H. [1 ]
Fang, S. [1 ]
机构：
[1] Nanjing Chest Hosp, Affiliated Brain Hosp Nanjing Med Univ, Nanjing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Neoadjuvant; Aumolertinib; Unresectable EGFR-mutant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-26
引用
收藏
页码：S651 / S651
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [22] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
  • [23] Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations
    Wen, Miaomiao
    Wang, Lei
    Wang, Xuejiao
    Yang, Sanhu
    Sun, Ying
    Xia, Jinghua
    Zhang, Yanning
    Zhang, Zhipei
    Huang, Lijun
    Jiang, Tao
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12) : 686 - 693
  • [24] Novel Approaches of Chemoradiotherapy in Unresectable Stage IIIA and Stage IIIB Non-Small Cell Lung Cancer
    Stinchcombe, Thomas E.
    Bogart, Jeffrey A.
    ONCOLOGIST, 2012, 17 (05): : 682 - 693
  • [25] Outcomes comparison between neoadjuvant chemotherapy and adjuvant chemotherapy in stage IIIA non-small cell lung cancer patients
    Tao, Xiaoting
    Yuan, Chongze
    Zheng, Difan
    Ye, Ting
    Pan, Yunjian
    Zhang, Yawei
    Xiang, Jiaqing
    Hu, Hong
    Chen, Haiquan
    Sun, Yihua
    JOURNAL OF THORACIC DISEASE, 2019, 11 (04) : 1443 - 1455
  • [26] Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer
    Bunn, Paul A., Jr.
    Gaspar, Laurie E.
    Weyant, Michael J.
    Mitchell, John D.
    CANCER, 2016, 122 (05) : 674 - 675
  • [27] Neoadjuvant EGFR-TKI therapy in Non-Small cell lung cancer
    Grant, Christopher
    Nagasaka, Misako
    CANCER TREATMENT REVIEWS, 2024, 126
  • [28] Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements
    Takenaka, Masaru
    Kuroda, Koji
    Tanaka, Fumihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, 30 (02) : 215 - 228
  • [29] Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The Netherlands
    Joosten, Pieter J. M.
    Damhuis, Ronald A. M.
    van Diessen, Judi N. A.
    de Langen, Joop A.
    Belderbos, Jose S. A.
    Smit, Egbert F.
    Klomp, Houke M.
    Veenhof, Alexander A. F. A.
    Hartemink, Koen J.
    ACTA ONCOLOGICA, 2020, 59 (07) : 748 - 752
  • [30] Building a better therapy for stage IIIA non-small cell lung cancer
    Evans, TL
    Donahue, DM
    Mathisen, DJ
    Lynch, TJ
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 191 - +
12345